NAD+ is not a single commercial product
NAD+ infusion or injection services and oral precursors such as nicotinamide riboside or NMN are different interventions. Marketing often merges them into one “boost NAD” promise.
What a biomarker can and cannot prove
Increasing a laboratory NAD-related marker does not establish improved memory, reversal of aging or longer life. Clinical benefits require controlled trials with patient-relevant outcomes.
What studies are missing
There is not robust proof that NAD+ injections reverse cognitive decline or biological aging in healthy people. Dose, formulation, comparator and study duration are essential context.
Real-world costs and risks
Ask about clinician assessment, product regulation, side effects, infusion logistics and total charges. A large price tag is not evidence of better results.
Our editorial approach
Evaluate human clinical outcomes and uncertainties before introducing provider links. Continue to distinguish evidence about citicoline and other supplements from evidence about NAD+ procedures.
What to do next
Write down your clinical question and compare the full terms from more than one source. Confirm professional licensing, specific product, pharmacy, fees and appropriate follow-up. If something is unclear, ask before paying.
Example: put these questions to work
A study showing a shift in an NAD-related blood marker might be exciting biochemistry, but it does not answer whether an infusion prevents dementia or improves day-to-day memory. The intervention, measured outcome and study population have to match the claim. Keep oral precursors and intravenous or injected NAD+ on separate lines; they do not have interchangeable evidence. A reader may reasonably choose not to buy a treatment until patient-relevant outcomes are better established.
A worksheet for your own notes
Use the headings from this guide as questions to take to a qualified professional or provider. Write down what you were told and when; do not rely on a screenshot without a date. If the explanation changes between an advertisement and a checkout screen, ask the company to reconcile it before payment. Keep a separate column for things that have not been confirmed.
- NAD+ is not a single commercial product: Ask which documents, evidence, costs or clinical decisions would let you answer this point confidently.
- What a biomarker can and cannot prove: Ask which documents, evidence, costs or clinical decisions would let you answer this point confidently.
- What studies are missing: Ask which documents, evidence, costs or clinical decisions would let you answer this point confidently.
- Real-world costs and risks: Ask which documents, evidence, costs or clinical decisions would let you answer this point confidently.
For a fair comparison, collect answers from at least two sources that are actually suitable for your location and clinical question. Document the pharmacy, prescriber, cancellation policy, clinical follow-up and expected recurring charges wherever medication is involved.
A claim to treat with caution
A shift in NAD-related biomarkers does not prove cognitive improvement or reversal of aging. It is reasonable to stop the process if the information you need is not available. The goal is to make an informed, voluntary decision, not to maximize the number of provider applications.
Provider information to compare
These are paid referral links for additional research, not medical endorsements. We may earn a commission if you choose a service. Confirm the actual terms and eligibility with the provider.